Osteoporosis: A Growing National Healthcare Crisis

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

March 1, 2008

Expiration Date:

March 1, 2010

Intended Audience:

Family medicine specialists
Bone metabolism experts
Preventive medicine specialists
Gynecologists
Nurse practitioners
Orthopedic surgeons
Consulting pharmacists
Internal medicine specialists
Endocrinologists
Women's health physicians
Geriatric nurse practitioners
Rheumatologists

Registration:

Enrollment for this course is complimentary, and clinicians are invited to attend this CME-certified webcast and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an
independent educational grant
from Roche Laboratories Inc.

Accreditation Statement for Jointly-Sponsored Programs:

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Faculty Disclosures:

E. Michael Lewiecki, M.D.
Grant/Research Support: Roche, GSK, Merck, P&G, Amgen, Novartis, Lilly, Wyeth
Consultant: Roche, GSK, Merck, P&G, Amgen, Novartis, Lilly, Wyeth
Speakers Bureau: Roche, GSK, Merck, P&G, Lilly

Stuart L. Silverman, M.D.
Grant/Research Support: Lilly, Merck, Novartis, Wyeth, P&G, Roche
Consultant: Amgen, Roche/GSK, Merck, Wyeth, Lilly, Novartis
Advisory Board: Amgen, Lilly, Merck, Novartis, P&G, Wyeth
Speakers Bureau: Lilly, Roche/GSK, Kyphon, Merck, Novartis, P&G

Mone Zaidi, M.D., PhD, FRCP
Grant/Research Support: P&G
Speakers Bureau: Merck, P&G, Aventis, GSK, Roche

Distinguished Program Faculty and Panel Members:

Mone Zaidi , MD, PhD, FRCP
(Program Chairman)
Professor of Medicine, Geriatrics & Physiology & Biophysics
Mount Sinai School of Medicine
New York, NY

E. Michael Lewiecki , MD
Clinical Assistant Professor of Medicine
University of New Mexico School of Medicine
Albuquerque, NM

Stuart L. Silverman , MD
Clinical Professor of Medicine
UCLA
Beverly Hills, CA

Educational Objectives:

• Primary care physicians, internists, family practitioners, osteopathic physicians, nurse practitioners, and specialists will learn to risk stratify patients at risk for osteoporosis and /or related complications, and identify optimal therapeutic approaches.
• Primary care physicians, internists, family practitioners, osteopathic physicians, nurse practitioners, and specialists will learn to undertake a systematic evaluation of patients at risk for osteoporosis, including radiological examination and appropriate laboratory markers.
• Primary care physicians, internists, family practitioners, osteopathic physicians, nurse practitioners, and specialists will learn evidence-based approaches to reducing progression of osteoporosis and risk of fracture complications.
• Clinicians will learn how to select safe and effective pharmacotherapy for prevention and treatment of postmenopausal osteoporosis.
• Clinicians will learn how landmark trials and analyses focusing on BMD, bisphosphonate therapy, predictive risk, and fracture reduction should guide clinical management of patients with osteoporosis.

Disclaimer:

Copyright © 2006 by Pharmatecture, LLC. All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations

Copyright (c) 2007 All rights reserved